EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level  |
|---|
   3.4.22.49 | Blast Crisis |
26087013 |
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.4.22.49 | Blast Crisis |
26937281 |
c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 3.4.22.49 | Breast Neoplasms |
30097312 |
EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer. |
unassigned |
0 |
| 3.4.22.49 | Breast Neoplasms |
32546141 |
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients. |
unassigned |
0 |
| 3.4.22.49 | Carcinoma |
18616699 |
Effect of separase depletion on ionizing radiation-induced cell cycle checkpoints and survival in human lung cancer cell lines. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 3.4.22.49 | Carcinoma, Non-Small-Cell Lung |
18616699 |
Effect of separase depletion on ionizing radiation-induced cell cycle checkpoints and survival in human lung cancer cell lines. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 3.4.22.49 | Communicable Diseases |
32277525 |
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper. |
unassigned |
0 |
| 3.4.22.49 | Communicable Diseases |
32374387 |
CMS Measure Stewards' Assessment of the Infectious Diseases Society of America's Position Paper on SEP-1. |
therapeutic application
unassigned |
1
0 |
| 3.4.22.49 | Endometrial Neoplasms |
33282948 |
TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
4
1
0 |
| 3.4.22.49 | Hepatitis B |
33308056 |
Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study. |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
